IP Library › Assignment 017353/0372
Patent Assignment
Reel/Frame 017353/0372

Confirmation of Exclusive Patent License

Recorded: 2005-12-20 Received: 2005-12-29 Pages: 11
Assignors
COLEY PHARMACEUTICAL GROUP, INC.
Executed: 2005-05-06
COLEY PHARMACEUTICAL GROUP, LTD.
Executed: 2005-05-06
COLEY PHARMACEUTICAL, GMBH
Executed: 2005-05-06
Assignee
PFIZER INC.
235 EAST 42ND STREET, NEW YORK, NY, 10017, UNITED STATES
Covered Properties (41)
Semi-Soft C-Class Immunostimulatory Oligonucleotides
Application: 11/255,100 →
Cell-free methods for identifying compounds that affect toll-like receptor 9 (TLR9) signaling
Application: 10/982,193 →
C-Class Oligonucleotide Analogs with Enhanced Immunostimulatory Potency
Methods and products for enhancing epitope spreading
Application: 10/973,927 →
Immunostimulatory nucleic acid molecules
Application: 10/956,745 →
Pharmaceutical composition comprising a polynucleotide and optionally an antigen especially for vaccination
Application: 10/894,655 →
Immunostimulatory Nucleic Acid Molecules
Application: 10/894,862 →
Methods and products for inducing mucosal immunity
Application: 10/888,886 →
Immunostimulatory nucleic acid molecules
Application: 10/884,852 →
Methods for Enhancing an Antigen-Specific Immune Response Using Cpg-Oligonucleotides
Application: 10/877,369 →
Methods of enhancing immune responses using cpg-oligonucleotides
Application: 10/876,892 →
Methods for regulating hematopoiesis using CpG-oligonucleotides
Application: 10/876,965 →
Immunostimulatory nucleic acid molecules
Application: 10/877,407 →
Immunostimulatory Nucleic Acid Molecules
Application: 10/847,642 →
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
Application: 10/831,775 →
Methods and Products for Identification and Assessment of Tlr Ligands
Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination
Application: 10/811,226 →
Immunomodulatory Oligonucleotides
Application: 10/789,536 →
Immunomodulatory oligonucleotides
Application: 10/789,353 →
Immunomodulatory oligonucleotides
Application: 10/789,051 →
5' Cpg Nucleic Acids and Methods of Use
Application: 10/735,592 →
Methods of Treating Cancer Using Immunostimulatory Oligonucleotides
Application: 10/719,493 →
Immunostimulatory nucleic acid molecules
Application: 10/679,710 →
Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer
Application: 10/668,050 →
Immunostimulatory Nucleic Acids
Application: 10/644,052 →
Immune stimulation by phosphorothioate oligonucleotide analogs
Application: 10/643,141 →
Immunomodulatory oligonucleotides
Application: 10/631,676 →
Immunostimulatory Nucleic Acid Molecules
Application: 10/619,279 →
Nucleic Acid Compositions for Stimulating Immune Responses
Application: 10/613,524 →
Nucleic Acid Compositions for Stimulating Immune Responses
Application: 10/613,749 →
Nucleic Acid Compositions for Stimulating Immune Responses
Application: 10/613,736 →
Nucleic Acid Compositions for Stimulating Immune Responses
Application: 10/613,228 →
Nucleic acid compositions for stimulating immune responses
Application: 10/613,739 →
Methods for regulating hematopoiesis using CpG-oligonucleotides
Application: 10/373,381 →
Combination motif immune stimulatory oligonucleotides with improved activity
Application: 10/224,523 →
Immunostimulatory nucleic acid molecules for activating dendritic cells
Application: 10/161,229 →
CpG-like nucleic acids and methods of use thereof
Application: 10/140,013 →
Method of Inducing an Antigen-Specific Immune Response by Administering a Synergistic Combination of Adjuvants Comprising Unmethylated Cpg-Containing Nucleic Acids and a Non-Nucleic Acid Adjuvant.
Application: 10/023,909 →
NUCLEIC ACIDS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
Application: 09/954,987 →
Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
Application: 09/888,326 →
Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
Application: 09/824,468 →